COMMITMENTS AND CONTINGENCIES - Narrative (Details) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Jun. 30, 2025 USD ($)	Mar. 31, 2025 USD ($)	Jun. 30, 2024 USD ($)	Sep. 30, 2025 USD ($) liability	Sep. 30, 2024 USD ($)	Dec. 31, 2022 USD ($) payment	Dec. 31, 2019 USD ($)
Loss Contingencies [Line Items]
Payment for contingent consideration				$ 16,451	$ 11,923
Arkis
Loss Contingencies [Line Items]
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)							$ 25,500
Contingent consideration							13,100
Arkis | Development Milestones
Loss Contingencies [Line Items]
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)							10,000
Payment for contingent consideration		$ 5,000
Arkis | Commercial Sales Milestones
Loss Contingencies [Line Items]
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)							$ 15,500
Derma Sciences
Loss Contingencies [Line Items]
Number of liabilities | liability				1
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)				$ 3,000
Derma Sciences | BioD Earnout Payments and Medihoney Earnout Payments
Loss Contingencies [Line Items]
Payment for contingent consideration				$ 33,300
ACell, Inc.
Loss Contingencies [Line Items]
Number of liabilities | liability				1
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)				$ 23,900
ACell, Inc. | Revenue-Based Performance Milestones In 2023
Loss Contingencies [Line Items]
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)				$ 100,000
Surgical Innovation Associates, Inc.
Loss Contingencies [Line Items]
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)						$ 90,000
Business acquisition, number of payments | payment						2
Surgical Innovation Associates, Inc. | Revenue Based Performance Milestones
Loss Contingencies [Line Items]
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)						$ 32,600
Payment for contingent consideration	$ 18,100		$ 12,400
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)						50,000
Surgical Innovation Associates, Inc. | FDA Approval Of Premarket Approval
Loss Contingencies [Line Items]
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)						25,000
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)						$ 40,000